Literature DB >> 15167823

Persistent vaginal discharge after uterine artery embolization for fibroid tumors: cause of the condition, magnetic resonance imaging appearance, and surgical treatment.

Woodruff J Walker1, Tyrone T Carpenter, Andrew S H Kent.   

Abstract

OBJECTIVE: The purpose of this study was to establish the cause of and treatment for chronic vaginal discharge after uterine artery embolization. STUDY
DESIGN: This was a retrospective review of the diagnosis and treatment of the procedure at 3 months.
RESULTS: In 94% of patients, the condition either completely resolved or diminished to a nonproblematic level.
CONCLUSION: The persistent discharge in these patients was due to a superficial cavity within the infarcted fibroid tumor that was communicating with the endometrial cavity through a hole in the endometrium. This situation is indicated by a specific appearance on TII sagittal magnetic resonance images. Hysteroscopic resection of the necrotic fibroid tumor cavity was usually curative.

Entities:  

Mesh:

Year:  2004        PMID: 15167823     DOI: 10.1016/j.ajog.2003.12.010

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

Review 1.  [Imaging before and after uterine artery embolization].

Authors:  T J Kröncke
Journal:  Radiologe       Date:  2008-07       Impact factor: 0.635

2.  Complications of uterine fibroid embolization.

Authors:  Brian E Schirf; Robert L Vogelzang; Howard B Chrisman
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

3.  Uterine restoration after repeated sloughing of fibroids or vaginal expulsion following uterine artery embolization.

Authors:  Hye Ri Park; Man Deuk Kim; Nack Keun Kim; Hee Jin Kim; Sang-Wook Yoon; Won Kyu Park; Mee Hwa Lee
Journal:  Eur Radiol       Date:  2005-02-24       Impact factor: 5.315

4.  Uterine Fibroid Embolization in a Series of Women Older Than 50 Years: An Observational Study.

Authors:  Benedetto Mondelli; Woodruff John Walker; Tanveer Dhanoya; Karen Morton
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.